Closing Bell: Nifty below 24,700, Sensex down 733 pts on fresh tariff concern

Indian benchmark indices ended lower on seventh consecutive session on September 26 Nifty below 24,700. At close, the Sensex was down 733.22 points or 0.90 percent at 80,426.46, and the Nifty was down 236.15 points or 0.95 percent at 24,654.70.

We wrap up today's edition of the Moneycontrol live market blog, and will be back Monday morning with all the latest updates and alerts. Please visit https://www.moneycontrol.com/markets/global-indices for all the global market action.

Markets remained under pressure and extended their losing streak for the sixth straight session. The tone was weak from the outset and worsened as the day progressed. Eventually, the Nifty closed near the day’s low at 24,654.70, down 0.95%. The decline was broad-based, with pharma and IT stocks leading the fall following U.S. tariff announcements on branded drugs. The broader indices bore the brunt of the sell-off, slipping nearly 2% each.

The announcement of tariffs on branded drugs weighed heavily on sentiment, adding to recent concerns over visa policy changes. IT counters were further dragged by weak guidance from global peers, while persistent FII outflows and a weak rupee amplified the pressure.

On the technical front, sustained weakness in heavyweights has accelerated the index’s decline over the past two sessions, with the Nifty now approaching its key support near the 200 DEMA around 24,400. Meanwhile, the sharp correction in mid- and small-cap stocks has further dampened market sentiment. Given this backdrop, we recommend adopting a cautious approach—focusing on fundamentally strong stocks while avoiding aggressive directional bets until clearer signals emerge.

Indian benchmark indices opened with a notable gap down, extended its weakness and closed even lower, reflecting strong selling pressure and cautious sentiment.

Two key factors weighed on the market mood today: First, President Trump’s announcement of 100% levy on branded and patented drugs, significantly impacted Indian pharma stocks, with the sector leading the declines. Second, signals of a patchy demand recovery from Accenture’s recent quarterly results triggered sharp losses in IT stocks.

Additionally, the Indian rupee is hovering near the record lows (88.70 at Friday’s close) despite a weakening US dollar. Relentless foreign outflows, higher US tariffs, visa fee hikes and persistent trade concerns have collectively fuelled the decline.

These developments weakened overall sentiment, resulting in Nifty breaking below key support zones and extending its losing streak for the sixth consecutive day.

In the sectoral space, all the sectors ended in the red. Pharma and IT Index were the top two sectoral losers, with both ending lower in the range of 2-2.5%. LT & Tata Motors were the top gainers, while Indusind Bank and M&M emerged as the top two losers.

Talking about the broader markets, both Midcap 100 and Smallcap 100, significantly underperformed the frontline indices. The Midcap 100 Index & Small cap 100 Index ended 2.05% and 2.26% lower respectively. The advance-decline ratio was heavily skewed in the favour of the bears with 459 stocks out of the Nifty 500 closing in the red, indicating selling across the board and weakening market breadth.

Nifty View

Nifty opened lower and extended its fall during the intraday session, closing at 24,655, down 0.95%. On the daily chart, it formed a big body bearish candle, indicating strong presence of sellers throughout the day over the buyers.

The index broke below its 61.8% Fibonacci retracement level (24807) of the prior up move from 24,405 to 25,449 and its 100-day EMA (24,747), indicating breach of a key support zone. On the weekly chart, Nifty formed a sizeable bearish candle and ended its three-week streak of green closes.

The RSI is trending downwards, settling just below the 40 level, which suggests weakening momentum and potential further downside. The ADX indicator shows the DI- line crossing above DI+ on the daily chart, signalling sellers gaining control over buyers. Additionally, Nifty broke below the midline of the Bollinger Bands, indicating increased bearish momentum and a shift toward the lower band, often seen as a sign of selling pressure building up.

Looking at key levels, the 24,450–24,500 zone will act as a crucial support for the Index. If the index slips below the level of 24,450, it will lead to further correction upto the 24,200 level. While, on the upside, the zone of 24,850-24,900 will act as a crucial resistance for the Index.

Bank Nifty View

Bank Nifty opened lower and consolidated in a range briefly before breaking down to close at 54,389, down 1.22%. On the daily chart, it broke below its 100-day EMA level of 54,901 and extended its fall for the third consecutive day, indicating sustained bearish momentum.

On the weekly chart, Bank Nifty formed a sizeable bearish candle, taking resistance around the 50% Fibonacci retracement zone (55,600-55,650) of its prior down move from 57,628 to 53,562. This resistance zone also coincided with the midline of the Bollinger Bands, where the price pulled back from the lower band up to the midline before falling again, highlighting the dominance of sellers.

The ADX has been falling, which indicates weakening trend strength and possible reduction in market momentum, suggesting the current move may lose steam. Overall, Bank Nifty’s price action signals bearish control with critical resistances holding firm at key technical levels.

Looking at key levels, the 54,100–54,000 zone will act as a crucial support for the Index. If the index slips below the level of 54,000, it will lead to further correction upto the 53,500 level. While, on the upside, the 100-day EMA zone of 54,900-55,000 will act as a crucial resistance for the Index.

#1 Market posts worst weekly fall in nearly 6 months

#2 Sensex & Nifty down nearly 3% each, Nifty Bank down 2%

#3 All the sectoral indices close in the red, Nifty IT down 8%

Risk off sentiment continued in equity markets, as markets extended losing streak for sixth straight session on across-the-board selling amid Trump's decision to impose 100% tariff on branded and patented drugs that further soured investors' sentiment.

The market is already reeling under multiple pain-points like strong FII selling, US-India trade uncertainty, depreciating rupee and bullion's rising appeal, which is making investors jittery.

The Indian market experienced a bloodbath, mirroring the rout across Asian markets. Investor sentiment was rattled by a fresh wave of tariffs targeting the pharmaceuticals, dragging pharma stocks deep into the red.

Meanwhile, Accenture’s weaker guidance and job cuts highlighted slowing IT spending, with AI-driven growth failing to meet expectations, prompting a broad sell-off in tech shares. Investors remain cautious, with a near-term focus on domestic investment and consumption amid global uncertainty.

The Indian Rupee has stabilized after a volatile week, with the consolidation phase being driven by central bank intervention to meet the month-end dollar demand. While this action provided a much-need pause, the rupee is not yet out of the woods and remains vulnerable to lingering concerns over US trade tariffs.

In the near term, we see resistance for spot USDINR at 88.80 and firm support at 88.20.

Indian rupee ended marginally lower at 88.71 per dollar on Friday versus previous close of 88.67.

Indian benchmark indices ended lower on seventh consecutive session on September 26 Nifty below 24,700.

At close, the Sensex was down 733.22 points or 0.90 percent at 80,426.46, and the Nifty was down 236.15 points or 0.95 percent at 24,654.70. About 912 shares advanced, 2828 shares declined, and 106 shares unchanged.

IndusInd Bank, Sun Pharma, M&M, Eternal, Tata Steel were among biggest losers on the Nifty, while gainers included L&T, Tata Motors, Eicher Motors, Reliance Industries, ITC.

All the sectoral indices ended in the red with bank, capital goods, consumer durables, metal, IT, telecom, pharma, PSU Bank down 1-2 percent.

BSE midcap and smallcap indices shed 2% each.

QIB – 0.17 times

NII - 0.08 times

Retail – 0.15 times

Employee Reserved - 0.30 times

Overall – 0.14 times

QIB – 0.04 times

NII - 6.01 times

Retail – 6.66 times

Overall – 4.63 times

QIB – 0.86 times

NII - 0.65 times

Retail – 0.70 times

Overall – 0.73 times

QIB – 4.55 times

NII - 3.47 times

Retail – 1.53 times

Overall – 2.79 times

#1 Reverse valuation suggests asset servicing business undervalued at current price

#2 Concerns over large client loss, ripple effects & regulatory risks weigh on sentiment

#3 Refute significant loss from large client, remain positive on new clients & momentum

#4 One-third of revenues are non-derivatives, regulatory impact on PBT likely below 50 percent

#5 Strong wealth management flows & potential IB upside are positive triggers

QIB – 3.05 times

NII - 2.71 times

Retail – 0.77 times

Overall – 1.25 times

QIB – 13.41 times

NII - 3.74 times

Retail – 2.91 times

Overall – 8.87 times

The Sensex was down 765.98 points or 0.94 percent at 80,393.70, and the Nifty was down 240.95 points or 0.97 percent at 24,649.90. About 808 shares advanced, 2886 shares declined, and 120 shares unchanged.

Welspun Corp was quoting at Rs 863.55, down Rs 11.60, or 1.33 percent.

It has touched an intraday high of Rs 882.60 and an intraday low of Rs 860.45.

It was trading with volumes of 31,017 shares, compared to its five day average of 12,824 shares, an increase of 141.86 percent.

In the previous trading session, the share closed down 0.40 percent or Rs 3.55 at Rs 875.15.

The share touched a 52-week high of Rs 994.60 and a 52-week low of Rs 650.35 on 10 June, 2025 and 21 November, 2024, respectively.

Currently, the stock is trading 13.18 percent below its 52-week high and 32.78 percent above its 52-week low.

Market capitalisation stands at Rs 22,763.77 crore.

The company has signed, a non-binding MOU with the Ministry of Food Processing Industries, Government of India, for an investment of up to Rs. 2000 crores over a period of 5 years.

TATA Consumer Products was quoting at Rs 1,121.25, down Rs 12.70, or 1.12 percent.

It has touched an intraday high of Rs 1,137.00 and an intraday low of Rs 1,119.90.

It was trading with volumes of 9,364 shares, compared to its five day average of 43,942 shares, a decrease of -78.69 percent.

In the previous trading session, the share closed down 0.49 percent or Rs 5.55 at Rs 1,133.95.

The share touched a 52-week high of Rs 1,215.00 and a 52-week low of Rs 884.00 on 27 September, 2024 and 20 December, 2024, respectively.

Currently, the stock is trading 7.72 percent below its 52-week high and 26.84 percent above its 52-week low.

Market capitalisation stands at Rs 110,952.37 crore.

#1 Headwinds largely behind, sales & margin resetting to new normal levels

#2 Q2FY26 may be weak but seen as good entry point, recovery expected in H2FY26

#3 Structural story intact, Titan better placed compared to peers on risk-adjusted basis

#4 Valued at 60x Sep-27 EPS, in-line with 10-year average

#5 EPS CAGR of 24 percent forecast over FY26–28

#1 MoD signs Rs 62,370 crore contract with company for 97 LCA Mk1A aircraft

#2 Order includes 68 fighters, 29 twin-seaters & associated equipment

#3 Delivery to begin in FY28 & will complete over a period of six years

#4 Company’s order book expected to reach Rs 2.45 lakh crore by the end of Q2FY26

The company informed that yesterday certain officials of the Income Tax Department visited some of the company’s offices in India for conducting a survey action under Section 133A of the Income Tax Act, 1961. The proceedings are underway and the Company is extending its full co-operation to the officials.

Raymond was quoting at Rs 604.00, down Rs 13.05, or 2.11 percent.

It has touched an intraday high of Rs 620.85 and an intraday low of Rs 602.55.

It was trading with volumes of 24,546 shares, compared to its five day average of 33,030 shares, a decrease of -25.68 percent.

In the previous trading session, the share closed down 0.27 percent or Rs 1.65 at Rs 617.05.

The share touched a 52-week high of Rs 1,908.35 and a 52-week low of Rs 530.00 on 11 December, 2024 and 14 May, 2025, respectively.

Currently, the stock is trading 68.35 percent below its 52-week high and 13.96 percent above its 52-week low.

Market capitalisation stands at Rs 4,021.05 crore.

Indian rupee is trading marginally lower at 88.71 per dollar versus previous close of 88.67.

Jindal Steel has marked a major milestone in India’s steelmaking industry by blowing in a 5 MTPA blast furnace. This achievement was realised with the commissioning of the Bhagavati Subhadrika Blast Furnace – II.

#1 Q4FY25 revenues at around USD 17.6 billion, up 4.5 percent YoY in constant currency

#2 Consulting up 3 percent YoY, managed services up 6 percent YoY in CC

#3 FY25 revenue growth at 7 percent YoY in CC, with 3 percent inorganic contribution

#4 FY26 CC rev growth guidance at 2–5 percent, includes 1.5 percent M&A contribution

#5 TTM bookings down 1 percent YoY, gross margins down 60 bps YoY

#6 Headcount down 1 percent YoY, North America/financial services growth at +5 percent / +12 percent YoY in CC

#7 Key trends for Indian IT to be watched closely

QIB – 3.39 times

NII - 2.05 times

Retail – 1.32 times

Overall – 2.06 times

#1 Reverse valuation suggests asset servicing business undervalued at current price

#2 Concerns over large client loss, ripple effects & regulatory risks weigh on sentiment

#3 Refute significant loss from large client, remain positive on new clients & momentum

#4 One-third of revenues are non-derivatives, regulatory impact on PBT likely below 50 percent

#5 Strong wealth management flows & potential IB upside are positive triggers

Nuvama Wealth Management was quoting at Rs 6,114.10, up Rs 82.90, or 1.37 percent. It has touched an intraday high of Rs 6,232.95 and an intraday low of Rs 5,992.75.

In the previous trading session, the share closed down 2.46 percent or Rs 152.40 at Rs 6,031.20.

The share touched a 52-week high of Rs 8,510.00 and a 52-week low of Rs 4,567.80 on 30 June, 2025 and 07 April, 2025, respectively. Currently, the stock is trading 28.15 percent below its 52-week high and 33.85 percent above its 52-week low. Market capitalisation stands at Rs 22,050.04 crore.

The company has received a show cause notice from the Joint Commissioner (Prev), CGST & Central Excise, Raipur, alleging invoicing by carrying and forwarding agents (C&FA) without the supply of cement during the period FY 2019-20 to September 24 of FY 2024-25, and hence demanding tax and penalty of Rs 112.48 crore.

Dixon Technologies was quoting at Rs 17,464.80, down Rs 727.75, or 4.00 percent.

It has touched an intraday high of Rs 18,209.30 and an intraday low of Rs 17,406.60.

It was trading with volumes of 14,591 shares, compared to its five day average of 5,549 shares, an increase of 162.96 percent.

In the previous trading session, the share closed up 0.19 percent or Rs 34.75 at Rs 18,192.55.

The share touched a 52-week high of Rs 19,149.80 and a 52-week low of Rs 12,326.60 on 17 December, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 8.8 percent below its 52-week high and 41.68 percent above its 52-week low.

Market capitalisation stands at Rs 105,685.90 crore.

QIB – 3.05 times

NII - 0.39 times

Retail – 0.61 times

Overall – 0.58 times

QIB – 8.63 times

NII - 2.32 times

Retail – 2.45 times

Overall – 5.79 times

#1 MoD signs contract with HAL to procure 97 LCA Mk1A aircraft for Rs 62,370 crore

#2 Delivery to begin in FY28 & will complete over a period of six years

#3 Aircraft to have over 64 percent indigenous content, with 67 new items added versus January 2021 contract

QIB – 0.00 times

NII - 0.05 times

Retail – 0.11 times

Employee Reserved - 0.24 times

Overall – 0.06 times

President Trump's announcement of 100% tariffs on branded and patented pharmaceutical imports from October 1st poses significant risks to India's pharmaceutical sector. The US accounts for 31% of India's $27.9 billion pharma exports. Major Indian generic companies like Dr Reddy's, Sun Pharma, and Aurobindo face serious margin pressure. They generally work with very narrow margins of 8-15% in the competitive US generics market.

Pricing pressure from pharmacy benefit managers and consolidated buyers already limits profitability. These companies face a binary choice: absorb potentially devastating tariff costs and operate at losses or pass through price increases to US consumers and insurers, risking substantial market share erosion to competitors with domestic manufacturing capabilities.

While tariffs primarily target branded drugs, uncertainty persists over complex generics inclusion. Companies with established US manufacturing facilities may gain competitive advantages, while innovator Wockhardt faces heightened barriers despite advancing six QIDP-designated anti-infective drugs through Phase III trials, lacking US facilities to capitalize on its differentiated pipeline in America's lucrative pharmaceutical market.

Tata Power Renewable Energy (TPREL), a subsidiary of The Tata Power Company has signed a Memorandum of Understanding (MoU) with Bank of Barodato facilitate financing solutions for MSME and Commercial & Industrial (C&I) customers opting for solar energy.

QIB – 0.03 times

NII - 4.81 times

Retail – 5.54 times

Overall – 3.81 times

Indian rupee is trading flat at 88.70 per dollar versus previous close of 88.67.

The Sensex was down 359.71 points or 0.44 percent at 80,799.97, and the Nifty was down 117.65 points or 0.47 percent at 24,773.20. About 927 shares advanced, 2695 shares declined, and 121 shares unchanged.

#1 Advances growth aligned with industry

#2 HL/PL disbursements picking up, SME traction to moderate from 30 percent

#3 Core NIM may contract mid-single digit

#4 Yield repricing offset by SA/TD cuts, LDR expansion & lower bulk deposit dependence

#5 Asset quality stable across retail & business segments

#6 Opex to rise on festive spend, PSLCs

#7 Focus remains on bulk deposit reduction, CASA mix improvement

QIB – 0.86 times

NII - 0.46 times

Retail – 0.55 times

Overall – 0.62 times

QIB – 0.46 times

NII - 1.46 times

Retail – 1.18 times

Overall – 1.04 times

QIB – 2.16 times

NII - 0.25 times

Retail – 0.51 times

Overall – 0.47 times

Waaree Energies was quoting at Rs 3,214.60, down Rs 230.50, or 6.69 percent.

It has touched an intraday high of Rs 3,385 and an intraday low of Rs 3,211.

In the previous trading session, the share closed down 1.28 percent or Rs 44.80 at Rs 3,445.10.

The share touched a 52-week high of Rs 3,865 and a 52-week low of Rs 1,863 on 12 September, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 16.83 percent below its 52-week high and 72.55 percent above its 52-week low.

Market capitalisation stands at Rs 92,465.05 crore.

QIB – 2.12 times

NII - 1.63 times

Retail – 2.17 times

Overall – 2.00 times

CIL–JSPPPL, the joint venture between Ceigall India and JSP Projects (JSPPPL), has received a Letter of Award from the Greater Mohali Area Development Authority (GMADA) for the construction of internal roads of Pocket B, C & D of Aerotropolis, SAS Nagar. The project is worth Rs 509.2 crore. Ceigall India and JSP Projects hold 80% and 20% stakes in the joint venture, respectively.

The company has received a Letter of Award from Talis Logistics, South Africa, for the supply and commissioning of overhauled in-service Cape gauge ALCO diesel-electric locomotives. The order is worth USD 18 million.

Biocon was quoting at Rs 339.60, down Rs 16.25, or 4.57 percent.

It has touched an intraday high of Rs 350.00 and an intraday low of Rs 339.60.

It was trading with volumes of 91,737 shares, compared to its five day average of 74,154 shares, an increase of 23.71 percent.

In the previous trading session, the share closed down 0.84 percent or Rs 3.00 at Rs 355.85.

The share touched a 52-week high of Rs 405.90 and a 52-week low of Rs 290.80 on 18 July, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 16.33 percent below its 52-week high and 16.78 percent above its 52-week low.

Market capitalisation stands at Rs 45,403.29 crore.

#1 Company launches 'SG premium', a brand to take competition head on, is a step in the right direction

#2 Q2 volume expected to grow 12 percent YoY to 850,000 tons, revenue in-line

#3 EBITDA expected to beat estimates by 8-10 percent, forecast at Rs 440 crore

Ventive Hospitality proposed to acquire a 76% stake in Soham Leisure Ventures, marking its entry into Goa's hospitality market. Soham owns the 104 operational keys Hilton Goa Resort and a land parcel in Goa.

Ventive Hospitality was quoting at Rs 739.65, down Rs 27.00, or 3.52 percent.

It has touched an intraday high of Rs 778 and an intraday low of Rs 737.

In the previous trading session, the share closed up 1.49 percent or Rs 11.25 at Rs 766.65.

The share touched a 52-week high of Rs 844.75 and a 52-week low of Rs 522.65 on 21 July, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 12.44 percent below its 52-week high and 41.52 percent above its 52-week low.

Market capitalisation stands at Rs 17,273.91 crore.

The Sensex was down 384.92 points or 0.47 percent at 80,774.76, and the Nifty was down 123.15 points or 0.49 percent at 24,767.70. About 916 shares advanced, 2646 shares declined, and 124 shares unchanged.

ICICI Bank was quoting at Rs 1,361.00, down Rs 14.50, or 1.05 percent.

It has touched an intraday high of Rs 1,370.40 and an intraday low of Rs 1,359.15.

It was trading with volumes of 94,578 shares, compared to its five day average of 276,258 shares, a decrease of -65.76 percent.

In the previous trading session, the share closed down 0.47 percent or Rs 6.45 at Rs 1,375.50.

The share touched a 52-week high of Rs 1,494.10 and a 52-week low of Rs 1,187.00 on 31 July, 2025 and 23 January, 2025, respectively.

Currently, the stock is trading 8.91 percent below its 52-week high and 14.66 percent above its 52-week low.

Market capitalisation stands at Rs 972,186.26 crore.

Jupiter Wagons was quoting at Rs 338.00, up Rs 14.10, or 4.35 percent.

It has touched an intraday high of Rs 345.90 and an intraday low of Rs 321.60.

It was trading with volumes of 1,360,072 shares, compared to its five day average of 80,498 shares, an increase of 1,589.58 percent.

In the previous trading session, the share closed down 1.02 percent or Rs 3.35 at Rs 323.90.

The share touched a 52-week high of Rs 588.00 and a 52-week low of Rs 270.20 on 12 December, 2024 and 03 March, 2025, respectively.

Currently, the stock is trading 42.52 percent below its 52-week high and 25.09 percent above its 52-week low.

Market capitalisation stands at Rs 14,348.03 crore.

Canara Bank was quoting at Rs 119.45, down Rs 1.85, or 1.53 percent.

It has touched an intraday high of Rs 121.35 and an intraday low of Rs 119.25.

It was trading with volumes of 1,969,757 shares, compared to its five day average of 3,002,953 shares, a decrease of -34.41 percent.

In the previous trading session, the share closed down 1.30 percent or Rs 1.60 at Rs 121.30.

The share touched a 52-week high of Rs 124.60 and a 52-week low of Rs 78.58 on 24 September, 2025 and 03 March, 2025, respectively.

Currently, the stock is trading 4.13 percent below its 52-week high and 52.01 percent above its 52-week low.

Market capitalisation stands at Rs 108,348.93 crore.

HFCL was quoting at Rs 73.65, down Rs 2.76, or 3.61 percent.

It has touched an intraday high of Rs 76.26 and an intraday low of Rs 73.40.

It was trading with volumes of 648,499 shares, compared to its five day average of 909,865 shares, a decrease of -28.73 percent.

In the previous trading session, the share closed up 0.92 percent or Rs 0.70 at Rs 76.41.

The share touched a 52-week high of Rs 156.40 and a 52-week low of Rs 68.58 on 27 September, 2024 and 29 August, 2025, respectively.

Currently, the stock is trading 52.91 percent below its 52-week high and 7.39 percent above its 52-week low.

Market capitalisation stands at Rs 10,625.29 crore.

L&T Finance was quoting at Rs 239.00, down Rs 4.90, or 2.01 percent.

It has touched an intraday high of Rs 244.10 and an intraday low of Rs 238.80.

It was trading with volumes of 98,885 shares, compared to its five day average of 179,872 shares, a decrease of -45.02 percent.

In the previous trading session, the share closed down 1.16 percent or Rs 2.85 at Rs 243.90.

The share touched a 52-week high of Rs 252.20 and a 52-week low of Rs 129.15 on 22 September, 2025 and 13 January, 2025, respectively.

Currently, the stock is trading 5.23 percent below its 52-week high and 85.06 percent above its 52-week low.

Market capitalisation stands at Rs 59,746.89 crore

CSM Technologies has filed the DRHP paper with SEBI.

QIB – 0.00 times

NII - 0.03 times

Retail – 0.07 times

Employee Reserved - 0.15 times

Overall – 0.04 times

QIB – 0.03 times

NII - 4.19 times

Retail – 4.84 times

Overall – 3.32 times

QIB – 0.86 times

NII - 0.39 times

Retail – 0.48 times

Overall – 0.57 times

The Sensex was down 382.13 points or 0.47 percent at 80,777.55, and the Nifty was down 118.00 points or 0.47 percent at 24,772.85. About 1050 shares advanced, 2413 shares declined, and 135 shares unchanged.

The Board of Directors of the company, has approved the interim dividend of Rs 2.50 per equity shares on face value of Re 1 per equity shares for the Financial Year 2025-26 amounting to Rs 705.50 millions.

Glenmark Pharma was quoting at Rs 1,994.05, down Rs 37.00, or 1.82 percent.

It has touched an intraday high of Rs 2,011.15 and an intraday low of Rs 1,972.55.

It was trading with volumes of 23,162 shares, compared to its five day average of 16,685 shares, an increase of 38.82 percent.

In the previous trading session, the share closed up 0.66 percent or Rs 13.25 at Rs 2,031.05.

The share touched a 52-week high of Rs 2,286.15 and a 52-week low of Rs 1,274.70 on 11 July, 2025 and 28 February, 2025, respectively.

Currently, the stock is trading 12.78 percent below its 52-week high and 56.43 percent above its 52-week low.

Market capitalisation stands at Rs 56,272.25 crore.

QIB – 0.46 times

NII - 0.70 times

Retail – 0.92 times

Overall – 0.74 times

QIB – 1.08 times

NII - 0.09 times

Retail – 0.35 times

Overall – 0.30 times

QIB – 1.64 times

NII - 0.73 times

Retail – 1.59 times

Overall – 1.38 times